0
Letters |

Hormone Therapy Use and Risk of Ovarian Cancer

Alastair H. MacLennan, MD; Rodney Baber, MD
JAMA. 2009;302(20):2203-2204. doi:10.1001/jama.2009.1724
Text Size: A A A
Published online

To the Editor: In their cohort study, Dr Mørch and colleagues1 investigated the association between use of hormone therapy (HT) and ovarian cancer. It is important to consider the potential for detection bias in all such observational studies.

The most common presentation of asymptomatic ovarian cancer is the chance finding of a pelvic mass at manual or ultrasonic pelvic examination.2 Women using HT are likely to present for routine pelvic examination more often than nonusers of HT. The potential for such detection bias was not discussed in the article but could account for the small annual increase in ovarian cancer incidence of 1 in 8300.

AUTHOR INFORMATION

Financial Disclosures: None reported.

REFERENCES

Mørch LS, Løkkegaard E, Andreasen AH, Krüger-Kjær S, Lidegaard Ø. Hormone therapy and ovarian cancer.  JAMA. 2009;302(3):298-305
PubMedCrossRef
van Nagell JR Jr, DePriest PD, Ueland FR,  et al.  Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened.  Cancer. 2007;109(9):1887-1896
PubMedCrossRef

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Mørch LS, Løkkegaard E, Andreasen AH, Krüger-Kjær S, Lidegaard Ø. Hormone therapy and ovarian cancer.  JAMA. 2009;302(3):298-305
PubMedCrossRef
van Nagell JR Jr, DePriest PD, Ueland FR,  et al.  Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened.  Cancer. 2007;109(9):1887-1896
PubMedCrossRef
November 25, 2009
Lina Steinrud Mørch, MSc; Øjvind Lidegaard, MD, DrMSci
JAMA. 2009;302(20):2203-2204.
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.